On October 2, 2019, Adicet Bio, Inc. closed the transaction. The transaction included participation from 18 investors including new investors aMoon Fund., DSC Investment Inc. (KOSDAQ:A241520), Handok, Inc. (KOSE:A002390), Johnson & Johnson Innovation - JJDC, Inc., KB Investment Co., Ltd., OCI Enterprises, Inc., Regeneron Pharmaceuticals, Inc. (NasdaqGS:REGN), Samsung Venture Investment Corporation, SBI JI Innovation Advisory Ltd., and Vincos Limited, and existing investors including Novartis Venture Funds, OrbiMed Advisors, L.L.C., Pontifax Ltd. Representative from Johnson & Johnson Innovation - JJDC, Inc. and Yair Schindel from aMoon Fund will join company's board of directors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,810 KRW | +1.20% | +4.81% | +21.34% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
13,650 KRW | 0.00% | -0.29% | 138M | ||
977.4 USD | -0.74% | +2.09% | 106B | ||
1.425 USD | +7.14% | -13.33% | 109M | ||
1st Jan change | Capi. | |
---|---|---|
+21.34% | 73.94M | |
+15.00% | 3.1B | |
+31.41% | 2.06B | |
+8.00% | 1.51B | |
-11.54% | 1.19B | |
+14.37% | 726M | |
+9.95% | 674M | |
+33.12% | 556M | |
-4.17% | 500M | |
+25.78% | 462M |
- Stock Market
- Equities
- A241520 Stock
- News DSC Investment Inc.
- Adicet Bio, Inc. announced that it has received $80 million in funding from a group of investors